Literature DB >> 19918335

Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

Liuyan Jiang1, Andrea D Abati, Wyndham Wilson, Maryalice Stetler-Stevenson, Constance Yuan.   

Abstract

Hepatosplenic (gammadelta) T-cell lymphoma (HSTCL) is an uncommon T-cell lymphoma with an aggressive clinical course and poor prognosis. Bone marrow and peripheral blood are frequently involved, with central nervous system involvement less common. We describe a case of a 31-year old man diagnosed with a gammadelta HSTCL in 2003, successfully treated with chemotherapy and allogeneic stem cell transplantation, and followed from 2003 to present. Four-color flow cytometry (FC) was performed on a BD FACSCalibur and data analyzed with CellQuest Pro and FCS Express software. For cerebrospinal fluid (CSF), all cells were acquired due to limited material. Cytological correlation was available on all specimens. Molecular studies for T-cell gene rearrangement were non-contributory. By FC, the diagnostic HSTCL immunophenotype was CD3 (+), CD7 (+), CD2 (+), CD5 (-), CD4 (-), CD8 (-), TCR gammadelta (+). Subsequent CSF FC analysis revealed a distinct population of gammadelta T-cells in all specimens, ranging from <1% to 13% of lymphocytes. Consistently, the gammadelta T-cells exhibited a different immunophenotypic profile from the reported diagnostic immunophenotype; they expressed CD5, and exhibited a heterogeneous pattern of CD8 expression. Comparison to in-house cases from patients with hairy cell leukemia and concomitant increases in non-neoplastic gammadelta T-cells was performed. The persistent gammadelta T-cells from the CSF of the patient with HSTCL were immunophenotypically consistent with non-neoplastic gammadelta T-cells. We describe an unusual case of persistent gammadelta T-cells in the CSF of a patient during 6 years of flow cytometric follow-up after treatment for gammadelta HSTCL. By cytology, non-neoplastic and malignant gammadelta T-cells are often difficult to distinguish. FC analysis helps to make this distinction, even with a limited panel. By FC, the gammadelta-T cells in the CSF of this patient are immunophenotypically consistent with non-neoplastic gammadelta T-cells. Remarkably, this finding is underscored by the patient's unusual clinical picture; he remains well and disease free.

Entities:  

Keywords:  Gamma-delta T cells; T-cell gene rearrangement; cerebrospinal fluid; flow cytometry; hepatosplenic T cell lymphoma

Mesh:

Substances:

Year:  2009        PMID: 19918335      PMCID: PMC2776263     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

1.  Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis.

Authors:  C A French; D M Dorfman; G Shaheen; E S Cibas
Journal:  Diagn Cytopathol       Date:  2000-12       Impact factor: 1.582

Review 2.  Gammadelta T cells: functional plasticity and heterogeneity.

Authors:  Simon R Carding; Paul J Egan
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

3.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

4.  Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase.

Authors:  Anja C Roden; William G Morice; Curtis A Hanson
Journal:  Arch Pathol Lab Med       Date:  2008-11       Impact factor: 5.534

5.  Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.

Authors:  F Vega; L J Medeiros; C Bueso-Ramos; D Jones; R Lai; R Luthra; L V Abruzzo
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

6.  Increased peripheral blood gamma delta T-cells in patients with lymphoid neoplasia: A diagnostic dilemma in flow cytometry.

Authors:  J McClanahan; P I Fukushima; M Stetler-Stevenson
Journal:  Cytometry       Date:  1999-12-15

7.  Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.

Authors:  L Recht; D J Straus; C Cirrincione; H T Thaler; J B Posner
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

8.  Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft.

Authors:  M Hirokawa; T Horiuchi; Y Kawabata; A Kitabayashi; A B Miura
Journal:  Bone Marrow Transplant       Date:  2000-07       Impact factor: 5.483

9.  Primary omental gamma/delta T-cell lymphoma involving the central nervous system.

Authors:  Y Harada; S Kato; H Komiya; T Shirota; K Mukai; T Hayashi
Journal:  Leuk Lymphoma       Date:  2004-09

Review 10.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  1 in total

Review 1.  Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia).

Authors:  Erick Crespo-Solis; Xavier López-Karpovitch; Jesús Higuera; Beatriz Vega-Ramos
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.